4.6 Review

Inhibitor of DNA binding/differentiation proteins as IDs for pancreatic cancer: Role in pancreatic cancer initiation, development and prognosis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

BMP9-ID1 Signaling Activates HIF-1α and VEGFA Expression to Promote Tumor Angiogenesis in Hepatocellular Carcinoma

Han Chen et al.

Summary: This study found that BMP9-ID1 signaling promotes angiogenesis in HCC by activating HIF-1α/VEGFA expression. Therefore, targeting BMP9-ID1 signaling could be an important therapeutic option for advanced HCC.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Genetics & Heredity

Inhibitor of DNA binding 2 knockdown inhibits the growth and liver metastasis of colorectal cancer

Fang Liu et al.

Summary: Id2 overexpression was found in CRC cell lines. Knockdown of Id2 reduced the proliferation, colony formation, migration and invasion of HCT116 cells. Id2 knockdown also reversed epithelial-mesenchymal transition and suppressed CRC liver metastasis.
Article Biochemistry & Molecular Biology

Expression of Id3 represses exhaustion of anti-tumor CD8 T cells in liver cancer

Yun Jin et al.

Summary: Id3 plays a protective role in CD8 T cells in liver cancer.

MOLECULAR IMMUNOLOGY (2022)

Article Oncology

Brain infiltration of breast cancer stem cells is facilitated by paracrine signaling by inhibitor of differentiation 3 to nuclear respiratory factor 1

Jayanta K. Das et al.

Summary: Understanding the molecular mechanism of how breast cancer cells infiltrate the brain is critical for developing treatment options. This study reveals a role for NRF1 and ID3 in the process of breast cancer stem cells crossing the blood-brain barrier and colonizing the brain, providing potential targets for preventing brain metastasis.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2022)

Article Multidisciplinary Sciences

ID1 marks the tumorigenesis of pancreatic ductal adenocarcinoma in mouse and human

Yuanxin Tang et al.

Summary: Pancreatic Ductal Adenocarcinoma (PDAC) is a deadly disease with increasing death rates and no effective treatment. The study suggests that ID1 is a critical determinant of PDAC development and progression, serving as a potential malignant biomarker for the disease.

SCIENTIFIC REPORTS (2022)

Article Oncology

Cancer Statistics, 2021

Rebecca L. Siegel et al.

Summary: Every year, the American Cancer Society projects the numbers of new cancer cases and deaths in the United States, with the latest data showing a significant decline in lung cancer mortality, while prostate cancer mortality has plateaued and breast and colorectal cancer mortality have slowed. Improvements in treatment have accelerated progress against lung cancer, leading to a record drop in overall cancer mortality.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Oncology

ID1 and ID4 Are Biomarkers of Tumor Aggressiveness and Poor Outcome in Immunophenotypes of Breast Cancer

Marta Garcia-Escolano et al.

Summary: Inhibitor of differentiation (ID) proteins play essential roles in promoting proliferation during embryonic development but are usually silenced in adult tissues. However, in breast cancer, ID4 is found to be significantly overexpressed, and both ID1 and ID4 overexpression are associated with aggressive tumor phenotypes and poor survival. These findings suggest that ID1 and ID4 may serve as biomarkers for tumor aggressiveness and prognosis in breast cancer, and potentially as targets for new treatments.

CANCERS (2021)

Article Oncology

ID4 predicts poor prognosis and promotes BDNF-mediated oncogenesis of colorectal cancer

Cam-Thu Ha et al.

Summary: The ID4-BDNF signaling pathway plays a crucial role in colorectal cancer, affecting tumor growth, migration, and chemosensitivity.

CARCINOGENESIS (2021)

Article Respiratory System

ID1 mediates resistance to osimertinib in EGFR T790M-positive non-small cell lung cancer through epithelial-mesenchymal transition

Kejun Liu et al.

Summary: Our study demonstrated that ID1 may induce EMT in EGFR T790M-positive NSCLC cells, mediating resistance to osimertinib. Changes in ID1 expression levels affected E-cadherin and vimentin expression, impacting cell proliferation, invasion, apoptosis, and cell cycle progression. These findings offer new insights and potential treatment strategies for EGFR mutated NSCLC post osimertinib resistance.

BMC PULMONARY MEDICINE (2021)

Article Oncology

Anti-tumor effects of an ID antagonist with no observed acquired resistance

Paulina M. Wojnarowicz et al.

Summary: AGX51 targets ID proteins in cancer cells, inhibiting cell growth and enhancing ROS production, showing potential therapeutic effects for multiple cancers.

NPJ BREAST CANCER (2021)

Article Oncology

ID1 Mediates Escape from TGFβ Tumor Suppression in Pancreatic Cancer

Yun-Han Huang et al.

CANCER DISCOVERY (2020)

Article Oncology

ID2 and GJB2 promote early-stage breast cancer progression by regulating cancer stemness

Yin Liu et al.

BREAST CANCER RESEARCH AND TREATMENT (2019)

Article Biochemistry & Molecular Biology

LncRNA SNHG7 promotes pancreatic cancer proliferation through ID4 by sponging miR-342-3p

Dongfeng Cheng et al.

CELL AND BIOSCIENCE (2019)

Article Cell Biology

A Small-Molecule Pan-Id Antagonist Inhibits Pathologic Ocular Neovascularization

Paulina M. Wojnarowicz et al.

CELL REPORTS (2019)

Article Oncology

Epigenetic regulation of ID4 in breast cancer: tumor suppressor or oncogene?

Daniela Nasif et al.

CLINICAL EPIGENETICS (2018)

Article Immunology

Id2 Collaborates with Id3 To Suppress Invariant NKT and Innate-like Tumors

Jia Li et al.

JOURNAL OF IMMUNOLOGY (2017)

Review Medicine, General & Internal

The TGF-β/Smad4 Signaling Pathway in Pancreatic Carcinogenesis and Its Clinical Significance

Sunjida Ahmed et al.

JOURNAL OF CLINICAL MEDICINE (2017)

Review Oncology

Epigenetic control of gene expression: Potential implications for cancer treatment

F. Perri et al.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)

Article Oncology

Id4 promotes cell proliferation in hepatocellular carcinoma

Yang Zhang et al.

CHINESE JOURNAL OF CANCER (2017)

Review Cell Biology

The Id-protein family in developmental and cancer-associated pathways

Cornelia Roschger et al.

CELL COMMUNICATION AND SIGNALING (2017)

Article Biochemistry & Molecular Biology

Id-1 promotes osteosarcoma cell growth and inhibits cell apoptosis via PI3K/AKT signaling pathway

Liang Hao et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)

Article Multidisciplinary Sciences

Genomic analyses identify molecular subtypes of pancreatic cancer

Peter Bailey et al.

NATURE (2016)

Article Oncology

Inflammation-induced S100A8 activates Id3 and promotes colorectal tumorigenesis

Xuemei Zhang et al.

INTERNATIONAL JOURNAL OF CANCER (2015)

Article Cell Biology

New Mutations of the ID1 Gene in Acute Myeloid Leukemia Patients

Chintana Tochareontanaphol et al.

PATHOBIOLOGY (2015)

Article Oncology

Downregulation of Id2 increases chemosensitivity of glioma

ZhenYu Zhao et al.

TUMOR BIOLOGY (2015)

Review Oncology

Oncogenic KRAS signalling in pancreatic cancer

S. Eser et al.

BRITISH JOURNAL OF CANCER (2014)

Review Oncology

The ID proteins: master regulators of cancer stem cells and tumour aggressiveness

Anna Lasorella et al.

NATURE REVIEWS CANCER (2014)

Article Gastroenterology & Hepatology

Understanding pancreatic cancer genomes

Mark J. Cowley et al.

JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2013)

Article Multidisciplinary Sciences

A Mechanism Linking Id2-TGFβ Crosstalk to Reversible Adaptive Plasticity in Neuroblastoma

Lina Chakrabarti et al.

PLOS ONE (2013)

Review Gastroenterology & Hepatology

What We Have Learned About Pancreatic Cancer From Mouse Models

Pedro A. Perez-Mancera et al.

GASTROENTEROLOGY (2012)

Review Cell Biology

Mutant p53: one name, many proteins

William A. Freed-Pastor et al.

GENES & DEVELOPMENT (2012)

Article Genetics & Heredity

The genetic landscape of mutations in Burkitt lymphoma

Cassandra Love et al.

NATURE GENETICS (2012)

Review Biochemistry & Molecular Biology

Hallmarks of Cancer: The Next Generation

Douglas Hanahan et al.

Article Oncology

Id3 modulates cellular localization of bHLH Ptf1-p48 protein

Marlene Dufresne et al.

INTERNATIONAL JOURNAL OF CANCER (2011)

Review Gastroenterology & Hepatology

Cystic precursors to invasive pancreatic cancer

Hanno Matthaei et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2011)

Article Surgery

Id1/Id3 Knockdown Inhibits Metastatic Potential of Pancreatic Cancer

Yasutaka Shuno et al.

JOURNAL OF SURGICAL RESEARCH (2010)

Article Medicine, Research & Experimental

Multiplexed methylation profiles of tumor suppressor genes and clinical outcome in lung cancer

Monica Castro et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2010)

Article Cell Biology

Activation of Wnt signalling in stroma from pancreatic cancer identified by gene expression profiling

Christian Pilarsky et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2008)

Article Multidisciplinary Sciences

Spontaneous induction of murine pancreatic intraepithelial neoplasia (mPanIN) by acinar cell targeting of oncogenic Kras in adult mice

Nils Habbe et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Article Biochemistry & Molecular Biology

BMP4 regulates pancreatic progenitor cell expansion through Id2

H Hua et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2006)

Review Oncology

ID family of helix-loop-helix proteins in cancer

J Perk et al.

NATURE REVIEWS CANCER (2005)

Article Multidisciplinary Sciences

Id-1 as a molecular target in therapy for breast cancer cell invasion and metastasis

S Fong et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)

Article Multidisciplinary Sciences

Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis

SP Thayer et al.

NATURE (2003)

Article Biochemistry & Molecular Biology

Downregulation of ID4 by promoter hypermethylation in gastric adenocarcinoma

ASW Chan et al.

ONCOGENE (2003)

Review Cell Biology

Id proteins in development, cell cycle and cancer

MB Ruzinova et al.

TRENDS IN CELL BIOLOGY (2003)

Review Oncology

Id proteins in epithelial cells

JP Coppé et al.

EXPERIMENTAL CELL RESEARCH (2003)

Review Cell Biology

Role of id family proteins in growth control

Y Yokota et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2002)

Article Biochemistry & Molecular Biology

The Id proteins and angiogenesis

R Benezra et al.

ONCOGENE (2001)

Article Biochemistry & Molecular Biology

Id and development

Y Yokota

ONCOGENE (2001)

Review Biochemistry & Molecular Biology

Id proteins in cell cycle control and cellular senescence

Z Zebedee et al.

ONCOGENE (2001)